Mock, A., Plath, M., Moratin, J., Tapken, M. J., Jäger, D., Krauß, J., . . . Plath, K. (2021). EGFR and PI3K pathway activities might guide drug repurposing in HPV-negative head and neck cancers. Frontiers in oncology, 11, . https://doi.org/10.3389/fonc.2021.678966
Chicago Style (17th ed.) CitationMock, Andreas, Michaela Plath, Julius Moratin, Maria Johanna Tapken, Dirk Jäger, Jürgen Krauß, Stefan Fröhling, Jochen Heß, and Karim Plath. "EGFR and PI3K Pathway Activities Might Guide Drug Repurposing in HPV-negative Head and Neck Cancers." Frontiers in Oncology 11 (2021). https://doi.org/10.3389/fonc.2021.678966.
MLA (9th ed.) CitationMock, Andreas, et al. "EGFR and PI3K Pathway Activities Might Guide Drug Repurposing in HPV-negative Head and Neck Cancers." Frontiers in Oncology, vol. 11, 2021, https://doi.org/10.3389/fonc.2021.678966.